Literature DB >> 21106671

Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response.

Grant D Barish1, Ruth T Yu, Malith Karunasiri, Corinne B Ocampo, Jesse Dixon, Chris Benner, Alexander L Dent, Rajendra K Tangirala, Ronald M Evans.   

Abstract

In the macrophage, toll-like receptors (TLRs) are key sensors that trigger signaling cascades to activate inflammatory programs via the NF-κB gene network. However, the genomic network targeted by TLR/NF-κB activation and the molecular basis by which it is restrained to terminate activation and re-establish quiescence is poorly understood. Here, using chromatin immunoprecipitation sequencing (ChIP-seq), we define the NF-κB cistrome, which is comprised of 31,070 cis-acting binding sites responsive to lipopolysaccharide (LPS)-induced signaling. In addition, we demonstrate that the transcriptional repressor B-cell lymphoma 6 (Bcl-6) regulates nearly a third of the Tlr4-regulated transcriptome, and that 90% of the Bcl-6 cistrome is collapsed following Tlr4 activation. Bcl-6-deficient macrophages are acutely hypersensitive to LPS and, using comparative ChIP-seq analyses, we found that the Bcl-6 and NF-κB cistromes intersect, within nucleosomal distance, at nearly half of Bcl-6-binding sites in stimulated macrophages to promote opposing epigenetic modifications of the local chromatin. These results reveal a genomic strategy for controlling the innate immune response in which repressive and inductive cistromes establish a dynamic balance between macrophage quiescence and activation via epigenetically marked cis-regulatory elements.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21106671      PMCID: PMC3003193          DOI: 10.1101/gad.1998010

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  36 in total

Review 1.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  BCL6 represses NFkappaB activity in diffuse large B-cell lymphomas.

Authors:  A Perez-Rosado; Mj Artiga; P Vargiu; A Sanchez-Aguilera; A Alvarez-Barrientos; Ma Piris
Journal:  J Pathol       Date:  2008-03       Impact factor: 7.996

3.  Transcriptional repressor BCL6 controls Th17 responses by controlling gene expression in both T cells and macrophages.

Authors:  Arpita Mondal; Deepali Sawant; Alexander L Dent
Journal:  J Immunol       Date:  2010-03-08       Impact factor: 5.422

4.  Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.

Authors:  P Dhordain; O Albagli; R J Lin; S Ansieau; S Quief; A Leutz; J P Kerckaert; R M Evans; D Leprince
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.

Authors:  E W Scott; M C Simon; J Anastasi; H Singh
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

Review 6.  Mechanisms of disease: Toll-like receptors in cardiovascular disease.

Authors:  Stefan Frantz; Georg Ertl; Johann Bauersachs
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2007-08

7.  Rac1 signaling modulates BCL-6-mediated repression of gene transcription.

Authors:  Patrícia Barros; Peter Jordan; Paulo Matos
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

8.  Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor.

Authors:  H Niu; B H Ye; R Dalla-Favera
Journal:  Genes Dev       Date:  1998-07-01       Impact factor: 11.361

9.  Bcl6 is a transcriptional repressor for the IL-18 gene.

Authors:  Nobue Takeda; Masafumi Arima; Nobuhide Tsuruoka; Seiji Okada; Masahiko Hatano; Akemi Sakamoto; Yoichi Kohno; Takeshi Tokuhisa
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

10.  BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.

Authors:  Samir Parekh; Jose M Polo; Rita Shaknovich; Przemyslaw Juszczynski; Paola Lev; Stella M Ranuncolo; Yingnan Yin; Ulf Klein; Giorgio Cattoretti; Riccardo Dalla Favera; Margaret A Shipp; Ari Melnick
Journal:  Blood       Date:  2007-06-01       Impact factor: 22.113

View more
  141 in total

1.  Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response.

Authors:  Caroline M W van Stijn; Jason Kim; Aldons J Lusis; Grant D Barish; Rajendra K Tangirala
Journal:  FASEB J       Date:  2014-11-12       Impact factor: 5.191

2.  Linking hematopoietic regeneration to developmental signaling pathways: a story of BMP and Wnt.

Authors:  Teresa V Bowman; Eirini Trompouki; Leonard I Zon
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

Review 3.  Macrophage polarization and plasticity in health and disease.

Authors:  Subhra K Biswas; Manesh Chittezhath; Irina N Shalova; Jyue-Yuan Lim
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 4.  Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states.

Authors:  Lionel B Ivashkiv
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

5.  Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.

Authors:  Ping Yang; Linlang Guo; Zhijian J Duan; Clifford G Tepper; Ling Xue; Xinbin Chen; Hsing-Jien Kung; Allen C Gao; June X Zou; Hong-Wu Chen
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

Review 6.  Exploiting genomics and natural genetic variation to decode macrophage enhancers.

Authors:  Casey E Romanoski; Verena M Link; Sven Heinz; Christopher K Glass
Journal:  Trends Immunol       Date:  2015-08-19       Impact factor: 16.687

7.  Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.

Authors:  Ding Ai; Hongfeng Jiang; Marit Westerterp; Andrew J Murphy; Mi Wang; Anjali Ganda; Sandra Abramowicz; Carrie Welch; Felicidad Almazan; Yi Zhu; Yury I Miller; Alan R Tall
Journal:  Circ Res       Date:  2014-03-31       Impact factor: 17.367

8.  BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection.

Authors:  Bibo Zhu; Ruixuan Zhang; Chaofan Li; Li Jiang; Min Xiang; Zhenqing Ye; Hirohito Kita; Ari M Melnick; Alexander L Dent; Jie Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

9.  The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression.

Authors:  Jon E Ramsey; Joseph D Fontes
Journal:  Mol Immunol       Date:  2013-08-14       Impact factor: 4.407

Review 10.  Macrophages: gatekeepers of tissue integrity.

Authors:  Yonit Lavin; Miriam Merad
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.